​

Cartesian Therapeutics Ownership | Who Owns Cartesian Therapeutics?

OverviewForecastRevenueFinancialsChart

Cartesian Therapeutics Ownership Summary

Cartesian Therapeutics is owned by 3.40% institutional investors, 60.76% insiders, and 35.85% retail investors. Fmr is the largest institutional shareholder, holding 8.30% of RNAC shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 1.78% of its assets in Cartesian Therapeutics shares.

RNAC Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockCartesian Therapeutics3.40%60.76%35.85%
SectorHealthcare Stocks 232.20%10.74%-142.94%
IndustryBiotech Stocks 382.11%10.55%-292.66%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fmr2.16M8.30%$22.03M
Blackrock funding, inc. /de609.70K2.34%$4.40M
Vanguard group541.23K2.08%$3.90M
Bioimpact capital380.00K1.46%$3.88M
Erste asset management gmbh271.70K1.04%$1.96M
Geode capital management255.54K0.98%$1.84M
683 capital management230.00K0.89%$2.35M
State street197.67K0.76%$2.02M
Privium fund management b.v.172.50K0.66%$1.24M
Northern trust91.29K0.35%$932.97K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Bioimpact capital380.00K0.64%$3.88M
Privium fund management b.v.172.50K0.23%$1.24M
683 capital management230.00K0.12%$2.35M
Miller financial services13.64K0.12%$98.37K
Gsa capital partners llp77.23K0.05%$557.00K
R squared10.31K0.03%$74.32K
Virtus investment advisers11.11K0.03%$113.56K
Twin focus capital partners19.50K0.03%$199.29K
Ikarian capital22.17K0.02%$226.54K
Erste asset management gmbh271.70K0.02%$1.96M

Top Buyers

HolderShares% AssetsChange
Privium fund management b.v.172.50K0.23%172.50K
Ubs group67.34K0.00%57.39K
Renaissance41.10K0.00%41.10K
Bridgeway capital management25.00K0.01%25.00K
Vanguard group541.23K0.00%20.51K

Top Sellers

HolderShares% AssetsChange
Siren---563.27K
Bioimpact capital380.00K0.64%-306.01K
Fmr2.16M0.00%-178.34K
Blackrock funding, inc. /de609.70K0.00%-39.65K
Freestone capital---25.92K

New Positions

HolderShares% AssetsChangeValue
Privium fund management b.v.172.50K0.23%172.50K$1.24M
Bridgeway capital management25.00K0.01%25.00K$255.50K
R squared10.31K0.03%10.31K$74.32K
Ubs asset management americas516.00-516.00$3.72K
Optiver b.v.80.00-80.00$818.00

Sold Out

HolderChange
Ifp advisors-1.00
True wealth design-2.00
Larson financial group-3.00
Truvestments capital-10.00
Gamma investing-15.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202513-81.16%883,349-85.20%30.64%6-79.31%5-72.22%
Sep 30, 202523-62.90%695,491-88.85%20.46%7-75.00%9-47.06%
Jun 30, 202566-2.94%6,395,690-2.83%243.81%29-12.12%18-
Mar 31, 2025684.62%6,582,0911.37%25145.00%33-25.00%18125.00%
Dec 31, 2024666.45%6,666,026-2.94%421.92%4528.57%8-11.11%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Growth Compy Commingled Pl S461.81K1.78%-1.10K
HBM Healthcare Investments AG Ord415.23K1.60%-
Fidelity Select Health Care368.99K1.42%-
Fidelity Select Biotechnology366.55K1.41%-
Fidelity Growth Company Fund341.34K1.31%-
Vanguard Total Stock Mkt Idx Inv280.91K1.08%-
iShares Russell 2000 ETF240.49K0.92%240.49K
Fidelity Advisor Health Care I230.25K0.89%-
Fidelity Advisor Biotechnology I167.95K0.66%167.95K
Vanguard US Total Market Shares ETF126.63K0.49%-

Recent Insider Transactions

DateNameRoleActivityValue
Jan 06, 2026Brunn Carsten President and CEOSell$162.08K
Jan 06, 2026Miljkovic Milos Chief Medical OfficerSell$24.37K
Jan 06, 2026Davis Blaine Chief Financial OfficerSell$72.23K
Dec 04, 2025BARABE TIMOTHY C-Buy$205.80K
Apr 11, 2025SPRINGER TIMOTHY A Buy$69.07K

Insider Transactions Trends

DateBuySell
2026 Q1-3
2025 Q41-
2025 Q210-
2025 Q1612
2024 Q42017

RNAC Ownership FAQ

Who Owns Cartesian Therapeutics?

Cartesian Therapeutics shareholders are primarily institutional investors at 3.40%, followed by 60.76% insiders and 35.84% retail investors. The average institutional ownership in Cartesian Therapeutics's industry, Biotech Stocks , is 382.11%, which Cartesian Therapeutics falls below.

Who owns the most shares of Cartesian Therapeutics?

Cartesian Therapeutics’s largest shareholders are Fmr (2.16M shares, 8.30%), Blackrock funding, inc. /de (609.7K shares, 2.34%), and Vanguard group (541.23K shares, 2.08%). Together, they hold 12.72% of Cartesian Therapeutics’s total shares outstanding.

Does Blackrock own Cartesian Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Cartesian Therapeutics.

Who is Cartesian Therapeutics’s biggest shareholder by percentage of total assets invested?

Bioimpact capital is Cartesian Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.64% of its assets in 380K Cartesian Therapeutics shares, valued at 3.88M$.

Who is the top mutual fund holder of Cartesian Therapeutics shares?

Fidelity Growth Compy Commingled Pl S is the top mutual fund holder of Cartesian Therapeutics shares, with 1.78% of its total shares outstanding invested in 461.81K Cartesian Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools